Torre Lazur wins AOR for Entereg

Share this article:
Torre Lazur McCann Healthcare Group was named AOR for Entereg—the first and only FDA-approved agent indicated to accelerate the time to upper and lower GI recovery following partial large or small bowel resection surgery with primary anastomosis—and will re-launch the brand for GlaxoSmithKline and Adolor.

Meanwhile, its sister agency, Torre Lazur McCann London, won the global launch for a new contraceptive by Bayer Schering Pharma, plus the re-launch across Europe of Invega for schizophrenia, an atypical antipsychotic that helps treat both the “positive” and the “negative” symptoms of schizophrenia.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"